Project Grant HT94252510258
Award Date
6/1/25
Completion Date
5/31/28
Dollars Obligated
$730K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Madison, WI 53715, USA
Similar Awards
This $777,500.00 federal Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420) supports a multiomic analysis of liquid biopsies for biomarker discovery and therapeutic targeting at the University of Wisconsin-Madison. The research, running from June 1, 2025 through May 31, 2028, aims to transform healthcare for military service members and the general public through innovative and impactful biomedical research. The...
This federal Project Grant award, valued at $155,500.00 and provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, is for the University of Wisconsin System to develop a model to study tumor-normal cell interaction in vitro for high-throughput drug screening. The research aims to transform healthcare for military service members and the broader public through innovative biomedical investigations. The one-year project will run from...
This $1,146,270 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Wisconsin System to target a lipid kinase regulator of nuclear Akt in breast cancer. The project aims to transform health care for Service Members and the American public through innovative and impactful research, with a focus on medical solutions for the battlefield. The grant will fund research activities at the University of...
This $785,833 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) supports advanced research to target immunotherapy-resistant lesions and eradicate oligometastatic prostate cancer. Awarded to the University of Wisconsin System, the research aims to transform healthcare for military service members and the broader public by investigating innovative approaches to disease prevention, diagnosis,...
This federal Project Grant award of $459,747.00, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research at the University of Wisconsin-Madison to define the effect of copy number amplification on the regulation of oncogenes in high-grade serous ovarian carcinoma. The research will examine the contributions of superenhancers at the 8q22 region, with the goal of advancing scientific understanding and potential treatment...
This federal Project Grant award, valued at $1,555,000.00 and provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program, will fund research at the University of Wisconsin - Madison to develop population modeling approaches for optimizing equitable ovarian cancer outcomes. The research efforts aim to transform healthcare for military service members and the general public by advancing innovative and impactful biomedical...
This federal Project Grant award of $1,146,270.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Wisconsin System. The grant supports research targeting a lipid kinase regulator of nuclear AKT in breast cancer, with a performance period from July 15, 2023 to July 14, 2026. The University of Wisconsin System, through its University of Wisconsin - Madison division, will conduct this biomedical research to...
The federal Project Grant award of $6,663,794.00, awarded on September 30, 2024 by the Defense Health Agency, supports the "PRECISIE RTD TRIAL: PRECISION WITH RETURN-TO-DUTY DECISIONS IN THE MILITARY" research initiative under the Military Medical Research and Development (CFDA 12.420) program. This grant will fund advanced biomedical research focused on transforming healthcare for military service members, with a particular emphasis on conditions relevant to military personnel and...
This federal Project Grant award, valued at $1,030,660.00, was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The primary awardee, The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., will conduct scientific investigations spanning basic, applied, and...
The federal Project Grant award in the amount of $2,402,721.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports the development of a patient monitoring and decision-support platform for precision health initiatives. The award was made to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., a non-profit organization that specializes in providing medical research, education, and...